A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension

doi: 10.11909/j.issn.1671-5411.2017.12.007

• King Sum Luk, 
• Christina Ip, 
• Meng–Qi GONG, 
• Sunny Hei WONG, 
• William KK Wu, 
• Mei DONG, 
• Guang–Ping LI, 
• Ka Pang Chan, 
• Yi–Mei DU, 
• Tong LIU, 
• Martin CS Wong, 
• David Shu, 
• Cheong Hui, 
• Gary Tse, 
• International Heath Informatics Study (IHIS) Network

• Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China

• Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China

• Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; University of British Columbia, Canada

• The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital, Shandong University, Jinan, China

• Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China

• Research Center of Ion Channelopathy, Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

• JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, LKS Institute of Health Sciences, Chinese University of Hong Kong